New Discovery Health Channel Program Emphasizes Tailored, Individualized Treatment for Metastatic Breast Cancer

October (National Breast Cancer Awareness Month) is already weeks behind us but it remains imperative for both physicians and patients to keep up-to-date on the latest treatment developments for breast cancer, as well as all types of cancer.Metastatic breast cancer is breast cancer that has spread beyond the breast into places such as the bones, lungs, liver, or brain....

US-based TGen Drug Development and France’s Institut Paoli-Calmettes Create New Alliance Focuses on Cancer

TGen Drug Development (TD2), a Scottsdale subsidiary of the Phoenix-based the Translational Genomics Research Institute (TGen) providing innovative services for oncology-focused biopharmaceutical companies using and the Institut Paoli-Calmettes (IPC), a comprehensive cancer center in Marseille, France which is part of a network of 20 cancer treatment centers in France, have forged a strategic alliance that will enable both to...

GlaxoSmithKline and bioMerieux Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment

France-based company bioMerieux, a world leader in the field of in vitro diagnostics for over 45 years and a provider of diagnostic solutions (reagents, instruments, software) designed to determine the source of disease and contamination to improve patient health and ensure consumer safety, has signed an agreement with GlaxoSmithKline (GSK) to develop a predictive test to help clinicians select...

right side

ads

Related articles